Adherex Technologies (FENC) was downgraded by Zacks Research from "hold" to "strong sell".
Fennec Pharmaceuticals Inc (FENC) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]
Fennec Pharmaceuticals GAAP EPS of -$0.17 misses by $0.21, revenue of $13.78M misses by $0.95M [Seeking Alpha]
Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026 [Yahoo! Finance]